{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:23:19Z","timestamp":1791235399556,"version":"4.1.0"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this world-wide survey was to evaluate the currently applied treatment options for the six most frequent peripheral vestibular disorders: benign paroxysmal positional vertigo (BPPV), acute unilateral vestibulopathy (AUVP)\/vestibular neuritis, Meni\u00e8re\u2019s disease (MD), bilateral vestibulopathy (BVP), vestibular paroxysmia (VP) and superior canal dehiscence syndrome (SCDS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>For the therapy of vestibular disorders, there are four treatment options: vestibular physical therapy (canalith repositioning maneuvers or balance training), pharmacotherapy, surgery, and psychotherapy. Since there are very few state-of-the-art RCTs, the treatment of vestibular disorders is so far not standardized and various methods are applied with heterogeneous efficacy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design\/methods<\/jats:title><jats:p>A web-based standardized survey questionnaire on the treatment of the six most frequent peripheral vestibular disorders was used to collect data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>234 replies from five continents, 47 countries, 162 cities and 188 centers were received: (% from all 234 replies; multiple answers possible): BPPV: posterior canal BPPV: 71% Epley, 40% Semont, and 12% others. Horizontal canal BPPV canalolithiasis: 58% Lempert (roll-over) maneuver, 33% Gufoni, 7% prolonged rest, and 9% others. Horizontal canal BPPV cupulolithiasis: 35% Gufoni, 27% Lempert (roll-over) maneuver, 9% Zuma, and 7% head shaking: AUVP: 79% pharmacotherapy, namely 47% glucocorticoids, 39% antiemetics, and 24% betahistine; 67% vestibular physical therapy. MD: 85% pharmacotherapy, namely 65% betahistine, 21% diuretics, 20% steroids, 16% antiemetics, 14% gentamicin; 37% surgery. VP: 65% pharmacotherapy, namely 57% anticonvulsants; 7% surgery. BVP: 77% vestibular physical therapy. SCDS: 50% surgery, namely 38.8% canal plugging, 23.3% capping and 15.5% resurfacing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this world-wide survey with 234 replies from 188 centers, widely heterogeneous applied treatment options were reported for the six most frequent peripheral vestibular disorders. This study shows in particular that certain drugs are often used despite low or very low evidence. Namely in AUVP, MD and VP well-designed controlled trials with clinically meaningful endpoints are needed.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2025.1540443","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T05:28:34Z","timestamp":1738646914000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["World-wide survey on the treatment of peripheral vestibular disorders"],"prefix":"10.3389","volume":"16","author":[{"given":"Michael","family":"Strupp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Lucca","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Laurell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Lehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Strobl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/MAO.0000000000002013","article-title":"Peripheral vestibular disorders: an epidemiologic survey in 70 million individuals","volume":"40","author":"H\u00fclse","year":"2019","journal-title":"Otol Neurotol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"Cd015171","DOI":"10.1002\/14651858.CD015171.pub2","article-title":"Systemic pharmacological interventions for M\u00e9ni\u00e8re's disease","volume":"2023","author":"Webster","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","first-page":"114","article-title":"Effects of diuretics and vasodilators therapy in Meniere\u2019s disease","volume":"27","author":"Khan","year":"2011","journal-title":"Biomedica"},{"key":"ref4","first-page":"44","article-title":"Multicenter randomized study on the efficacy of isosorbide in patients with M\u00e8ni\u00e9re's disease","volume":"15","author":"Park","year":"2016","journal-title":"Res Vestibular Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/01.mao.0000185057.81962.51","article-title":"Oral administration of prednisone to control refractory vertigo in M\u00e9ni\u00e8re's disease: a pilot study","volume":"26","author":"Morales-Luckie","year":"2005","journal-title":"Otol Neurotol"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-78260-3","volume-title":"Vertigo and dizziness: Common complaints","author":"Strupp","year":"2023"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD015245.pub2","article-title":"Intratympanic corticosteroids for M\u00e9ni\u00e8re\u2019s disease","volume":"2023","author":"Webster","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD015246.pub2","article-title":"Intratympanic gentamicin for M\u00e9ni\u00e8re\u2019s disease","volume":"2","author":"Webster","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD015249.pub2","article-title":"Surgical interventions for M\u00e9ni\u00e8re\u2019s disease","volume":"2023","author":"Lee","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/0194599816678386","article-title":"The effect of vestibular rehabilitation in patients with M\u00e9ni\u00e8re's disease","volume":"156","author":"van Esch","year":"2017","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD005397.pub4","article-title":"Vestibular rehabilitation for unilateral peripheral vestibular dysfunction","volume":"2015","author":"McDonnell","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00405-013-2596-8","article-title":"Meta-analysis of clinical studies with betahistine in M\u00e9ni\u00e8re\u2019s disease and vestibular vertigo","volume":"271","author":"Nauta","year":"2014","journal-title":"Eur Arch Otorrinolaringol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3109\/00016489.2015.1072873","article-title":"Use of betahistine in the treatment of peripheral vertigo","volume":"135","author":"Ramos Alcocer","year":"2015","journal-title":"Acta Otolaryngol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e0237523","DOI":"10.1371\/journal.pone.0237523","article-title":"Pharmacologic and surgical therapies for patients with Meniere's disease: a systematic review and network meta-analysis","volume":"15","author":"Ahmadzai","year":"2020","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"460","DOI":"10.14639\/0392-100X-2035","article-title":"Report from a consensus conference on the treatment of M\u00e9ni\u00e8re's disease with betahistine: rationale, methodology and results","volume":"38","author":"Casani","year":"2018","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000515821","article-title":"Betahistine in M\u00e9ni\u00e8re's disease or syndrome: a systematic review","volume":"27","author":"Van Esch","year":"2022","journal-title":"Audiol Neurootol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/bmjebm-2020-111410","article-title":"Interventions for Meni\u00e8re's disease: an umbrella systematic review","volume":"27","author":"van Esch","year":"2022","journal-title":"BMJ Evid Based Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"h6816","DOI":"10.1136\/bmj.h6816","article-title":"Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial)","volume":"352","author":"Adrion","year":"2016","journal-title":"BMJ"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1271640","DOI":"10.3389\/fneur.2023.1271640","article-title":"Examination of betahistine bioavailability in combination with the monoamine oxidase B inhibitor, selegiline, in humans-a non-randomized, single-sequence, two-period titration, open label single-center phase 1 study (PK-BeST)","volume":"14","author":"Strupp","year":"2023","journal-title":"Front Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s00405-015-3731-5","article-title":"Expression of histamine receptors in the human endolymphatic sac: the molecular rationale for betahistine use in Menieres disease","volume":"273","author":"M\u00f8ller","year":"2016","journal-title":"Eur Arch Otorrinolaringol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3233\/VES-130494","article-title":"Neuropharmacological basis of vestibular system disorder treatment","volume":"23","author":"Soto","year":"2013","journal-title":"J Vestib Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/B978-0-444-63437-5.00014-5","article-title":"Principles of vestibular pharmacotherapy","volume":"137","author":"Chabbert","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.expneurol.2014.08.013","article-title":"The mixed blessing of treating symptoms in acute vestibular failure \u2014 evidence from a 4-aminopyridine experiment","volume":"261","author":"Beck","year":"2014","journal-title":"Exp Neurol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMoa033280","article-title":"Methylprednisolone, valacyclovir, or the combination for vestibular neuritis","volume":"351","author":"Strupp","year":"2004","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1097\/MAO.0b013e3182267e24","article-title":"Treatment of acute vestibular neuronitis with glucocorticoids","volume":"32","author":"Karlberg","year":"2011","journal-title":"Otol Neurotol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1007\/s00415-015-7918-x","article-title":"Glucocorticoids improve acute dizziness symptoms following acute unilateral vestibulopathy","volume":"262","author":"Batuecas-Caletr\u00edo","year":"2015","journal-title":"J Neurol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/MAO.0000000000002106","article-title":"Steroids for acute vestibular Neuronitis-the earlier the treatment, the better the outcome?","volume":"40","author":"Sj\u00f6gren","year":"2019","journal-title":"Otol Neurotol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/0194599820982910","article-title":"Systematic review and Meta-analysis: effectiveness of corticosteroids in treating adults with acute vestibular neuritis","volume":"165","author":"Leong","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/acem.14728","article-title":"Guidelines for reasonable and appropriate care in the emergency department 3 (GRACE-3): acute dizziness and vertigo in the emergency department","volume":"30","author":"Edlow","year":"2023","journal-title":"Acad Emerg Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/coa.13880","article-title":"Therapeutic effect of steroids on vestibular neuritis: systematic review and meta-analysis","volume":"47","author":"Kim","year":"2022","journal-title":"Clin Otolaryngol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1177\/0091270010369241","article-title":"Betahistine treatment improves the recovery of static symptoms in patients with unilateral vestibular loss","volume":"51","author":"Redon","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3233\/VES-130496","article-title":"Betahistine treatment in managing vertigo and improving vestibular compensation: clarification","volume":"23","author":"Lacour","year":"2013","journal-title":"J Vestib Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/WCO.0000000000000632","article-title":"Vestibular rehabilitation: advances in peripheral and central vestibular disorders","volume":"32","author":"Dunlap","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3760\/cma.j.cn112137-20230824-00295","article-title":"Efficacy evaluation of short-term personalized vestibular rehabilitation in the treatment of acute unilateral vestibulopathy","volume":"104","author":"Lei","year":"2024","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/NPT.0000000000000382","article-title":"Vestibular rehabilitation for peripheral vestibular Hypofunction: an updated clinical practice guideline from the academy of neurologic physical therapy of the American Physical Therapy Association","volume":"46","author":"Hall","year":"2022","journal-title":"J Neurol Phys Ther"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1001\/jamaoto.2014.48","article-title":"Corticosteroids and vestibular exercises in vestibular neuritis. Single-blind randomized clinical trial","volume":"140","author":"Goudakos","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3233\/VES-180645","article-title":"Corticosteroids versus vestibular rehabilitation in long-term outcomes in vestibular neuritis","volume":"28","author":"Ismail","year":"2018","journal-title":"J Vestib Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"Cd003162","DOI":"10.1002\/14651858.CD003162.pub3","article-title":"The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo","volume":"2014","author":"Hilton","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599816689667","article-title":"Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update)","volume":"156","author":"Bhattacharyya","year":"2017","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.nrl.2010.01.004","article-title":"Meta-analysis on the efficacy of Epley's manoeuvre in benign paroxysmal positional vertigo","volume":"25","author":"Prim-Espada","year":"2010","journal-title":"Neurologia"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S0194-59989570010-2","article-title":"Randomized trial of the canalith repositioning procedure","volume":"113","author":"Lynn","year":"1995","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1136\/jnnp.2005.085894","article-title":"Short-term efficacy of Epley's manoeuvre: a double-blind randomised trial","volume":"77","author":"von Brevern","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0025-6196(11)64615-6","article-title":"The canalith repositioning procedure for the treatment of benign paroxysmal positional vertigo: a randomized controlled trial","volume":"75","author":"Froehling","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/00005537-200305000-00011","article-title":"A randomized trial of the canalith repositioning procedure","volume":"113","author":"Yimtae","year":"2003","journal-title":"Laryngoscope"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.amjoto.2003.09.010","article-title":"Treatment variations on the Epley maneuver for benign paroxysmal positional vertigo","volume":"25","author":"Cohen","year":"2004","journal-title":"Am J Otolaryngol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3238\/arztebl.2008.0173","article-title":"Diagnosis and treatment of vertigo and dizziness","volume":"105","author":"Strupp","year":"2008","journal-title":"Dtsch Arztebl Int"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/archotol.129.6.629","article-title":"Efficacy of the Semont maneuver in benign paroxysmal positional vertigo","volume":"129","author":"Levrat","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s00415-011-6272-x","article-title":"Double-blind randomized trial on short-term efficacy of the Semont maneuver for the treatment of posterior canal benign paroxysmal positional vertigo","volume":"259","author":"Mandal\u00e0","year":"2012","journal-title":"J Neurol"},{"key":"ref49","first-page":"7","article-title":"Benign paroxysmal positional vertigo: a comparative prospective study on the efficacy of Semont's maneuver and no treatment strategy","volume":"154","author":"Salvinelli","year":"2003","journal-title":"Clin Ter"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/lary.25688","article-title":"Epley and Semont maneuvers for posterior canal benign paroxysmal positional vertigo: a network meta-analysis","volume":"126","author":"Liu","year":"2016","journal-title":"Laryngoscope"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1001\/jamaneurol.2023.1408","article-title":"The Semont-plus maneuver or the Epley maneuver in Posterior Canal benign paroxysmal positional Vertigo: a randomized clinical study","volume":"80","author":"Strupp","year":"2023","journal-title":"JAMA Neurol"},{"key":"ref52","volume-title":"Thomas Brandt, und Marianne Dieterich,","author":"Strupp","year":"2022"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e704","DOI":"10.1097\/MAO.0000000000003586","article-title":"Vitamin D supplementation for benign paroxysmal positional Vertigo: a systematic review","volume":"43","author":"Hong","year":"2022","journal-title":"Otol Neurotol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1007\/s12070-021-03070-1","article-title":"Relation between Posterior Canal benign paroxysmal positional Vertigo and vitamin D deficiency","volume":"74","author":"Sharma","year":"2022","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"e666","DOI":"10.1055\/s-0041-1730992","article-title":"Therapeutic effect of the correction of vitamin D deficiency in patients with benign paroxysmal positional Vertigo. A randomized clinical trial. Int","volume":"26","author":"Mancera S\u00e1nchez","year":"2022","journal-title":"Arch Otorhinolaryngol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"e1225","DOI":"10.1002\/lio2.1225","article-title":"Vitamin D supplementation in preventing the recurrence of benign paroxysmal positional vertigo","volume":"9","author":"Kong","year":"2024","journal-title":"Laryngoscope investigative otolaryngol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1471-2377-14-110","article-title":"Association between osteoporosis and benign paroxysmal positional vertigo: a systematic review","volume":"14","author":"Yu","year":"2014","journal-title":"BMC Neurol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/jamaoto.2014.2941","article-title":"Seasonality of benign paroxysmal positional Vertigo","volume":"141","author":"Whitman","year":"2015","journal-title":"JAMA Otolaryngology\u2013Head & Neck Surgery"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"104212","DOI":"10.1016\/j.amjoto.2023.104212","article-title":"Assessment of vitamin D deficiency in recurrent BPPV patients: a cross-sectional study","volume":"45","author":"Ren","year":"2024","journal-title":"Am J Otolaryngol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1007\/s00405-018-5146-6","article-title":"Association of benign paroxysmal positional vertigo with vitamin D deficiency: a systematic review and meta-analysis","volume":"275","author":"AlGarni","year":"2018","journal-title":"Eur Arch Otorrinolaringol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/0003489419892285","article-title":"The impact of Betahistine versus Dimenhydrinate in the resolution of residual dizziness in patients with benign paroxysmal positional Vertigo: a randomized clinical trial","volume":"129","author":"Jalali","year":"2020","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.bjorl.2020.07.011","article-title":"Betahistine add-on therapy for treatment of subjects with posterior benign paroxysmal positional vertigo: a randomized controlled trial","volume":"88","author":"Sayin","year":"2022","journal-title":"Braz J Otorhinolaryngol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.2147\/NDT.S182809","article-title":"Efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigo","volume":"14","author":"Wan","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/0194599819881437","article-title":"Effectiveness of canal occlusion for intractable Posterior Canal benign paroxysmal positional Vertigo: a systematic review","volume":"162","author":"Maas","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1212\/WNL.0b013e3182648b8b","article-title":"Randomized clinical trial for geotropic horizontal canal benign paroxysmal positional vertigo","volume":"79","author":"Kim","year":"2012","journal-title":"Neurology"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"E1296","DOI":"10.1002\/lary.28981","article-title":"Double-blind randomized trial on the efficacy of the forced prolonged position for treatment of Lateral Canal benign paroxysmal positional Vertigo","volume":"131","author":"Mandal\u00e0","year":"2021","journal-title":"Laryngoscope"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/00016489.2020.1736339","article-title":"Double-blind randomized controlled trial on efficacy of cupulolith repositioning maneuver for treatment of apogeotropic horizontal canal benign paroxysmal positional vertigo","volume":"140","author":"Kong","year":"2020","journal-title":"Acta Otolaryngol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"740599","DOI":"10.3389\/fneur.2021.740599","article-title":"Diagnostic and therapeutic maneuvers for Anterior Canal BPPV Canalithiasis: three-dimensional simulations","volume":"12","author":"Bhandari","year":"2021","journal-title":"Front Neurol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"24","DOI":"10.17116\/jnevro202312304124","article-title":"Bilateral peripheral vestibulopathy","volume":"123","author":"Zhiznevskiy","year":"2023","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10162-023-00906-1","article-title":"The next challenges of vestibular implantation in humans","volume":"24","author":"Stultiens","year":"2023","journal-title":"J Assoc Res Otolaryngol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00415-017-8682-x","article-title":"A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine","volume":"265","author":"Bayer","year":"2018","journal-title":"J Neurol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/CPJ.0000000000000610","article-title":"Treatment of vestibular paroxysmia with lacosamide","volume":"9","author":"Strupp","year":"2019","journal-title":"Neurol Clin Pract"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00415-015-7973-3","article-title":"Vestibular paroxysmia: a treatable neurovascular cross-compression syndrome","volume":"263","author":"Brandt","year":"2016","journal-title":"J Neurol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11940-016-0417-2","article-title":"Therapy of vestibular Paroxysmia, superior oblique Myokymia, and ocular Neuromyotonia","volume":"18","author":"Strupp","year":"2016","journal-title":"Curr Treat Options Neurol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1212\/WNL.0000000000005755","article-title":"Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy: report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of neurology and the American Epilepsy Society","volume":"91","author":"Kanner","year":"2018","journal-title":"Neurology"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1034\/j.1600-0404.2001.104002110.x","article-title":"Gabapentin in the treatment of hemifacial spasm","volume":"104","author":"Daniele","year":"2001","journal-title":"Acta Neurol Scand"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1056\/NEJM198406283102604","article-title":"Disabling positional vertigo","volume":"310","author":"Jannetta","year":"1984","journal-title":"N Engl J Med"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF01401831","article-title":"Microvascular decompression of the eighth nerve in patients with disabling positional vertigo: selection criteria and operative results in 207 patients","volume":"125","author":"M\u00f8ller","year":"1993","journal-title":"Acta Neurochir"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3233\/VES-200004","article-title":"Superior semicircular canal dehiscence syndrome: diagnostic criteria consensus document of the committee for the classification of vestibular disorders of the B\u00e1r\u00e1ny society","volume":"31","author":"Ward","year":"2021","journal-title":"J Vestib Res"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fneur.2017.00347","article-title":"Heterogeneity in reported outcome measures after surgery in Superior Canal dehiscence syndrome-a systematic literature review","volume":"8","author":"Ossen","year":"2017","journal-title":"Front Neurol"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-0037-1599785","article-title":"Superior Semicircular Canal dehiscence syndrome - diagnosis and surgical management. Int","volume":"21","author":"Palma Diaz","year":"2017","journal-title":"Arch Otorhinolaryngol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00405-008-0840-4","article-title":"Efficacy assessment and complications of surgical management for superior semicircular canal dehiscence: a meta-analysis of published interventional studies","volume":"266","author":"Vlastarakos","year":"2009","journal-title":"Eur Arch Otorrinolaringol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1540443\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T05:28:40Z","timestamp":1738646920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1540443\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":82,"alternative-id":["10.3389\/fneur.2025.1540443"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1540443","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"article-number":"1540443"}}